Lv2
195 积分 2021-03-21 加入
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
3个月前
已完结
Lazertinib for patients with NSCLC harboring uncommon EGFR mutations: A phase II multi-center trial
4个月前
已完结
Lazertinib for patients with NSCLC harboring uncommon EGFR mutations: A phase II multi-center trial
4个月前
已完结
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834
4个月前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
